Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
3,530
datasets available to search
ShareScore release 0.9.0
Dataset results
3,530 results for “Non-small cell lung cancer;”
Study of Durvalumab Given With Chemoradiation Therapy in Patients With Unresectable Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT03519971. IPD Sharing: YES. Countries: 14. Publications: 0.
Study of Dovitinib and Biomarkers in Advanced Non-Small Cell Lung Cancer or Advanced Colorectal Cancer
ClinicalTrials.gov study NCT01676714. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Expanded Access Study of Afatinib in Treatment-naive or Chemotherapy Pre-treated Patients With Non-small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT01931306. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Treating Early-stage Non-Small Cell Lung Cancer With Durvalumab and Radiation Therapy
ClinicalTrials.gov study NCT04716946. IPD Sharing: YES. Countries: 1. Publications: 0.
Photodynamic Therapy Using HPPH in Treating Patients With Advanced Non-Small Cell Lung Cancer That Blocks the Air Passages
ClinicalTrials.gov study NCT00528775. IPD Sharing: Not stated. Countries: 1. Publications: 0.
MK2206 and Erlotinib Hydrochloride in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Progressed After Previous Response to Erlotinib Hydrochloride Therapy
ClinicalTrials.gov study NCT01294306. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Sym004 in Subjects With Stage IV Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT02083679. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Immunotherapy With or Without SBRT in Patients With Stage IV Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT03867175. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT06899126. IPD Sharing: YES. Countries: 12. Publications: 0.
A Study to Compare Ociperlimab Plus Tislelizumab Versus Durvalumab Following Concurrent Chemoradiotherapy (cCRT) in Participants With Stage III Unresectable Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT04866017. IPD Sharing: YES. Countries: 5. Publications: 0.
Romidepsin and Erlotinib Hydrochloride in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT01302808. IPD Sharing: NO. Countries: 1. Publications: 0.
Trial of Trametinib and Ponatinib in Patients With KRAS Mutant Advanced Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT03704688. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Study to Determine Progression-free Survival (PFS) and Evaluate Participant Experience for Participants With Metastatic Anaplastic Lymphoma Kinase-positive (ALK+) Non-Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT03546894. IPD Sharing: YES. Countries: 1. Publications: 0.
S0526: Pemetrexed Disodium in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00265785. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Local Ablative Therapy (LAT) in People With Non-Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT05429320. IPD Sharing: YES. Countries: 1. Publications: 0.
Ph II Concurrent Chemo t/Docetaxel/Carboplatin/Radio Therapy-consolidation t/Locally Adv Inoperable Non-Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT00664105. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pembrolizumab With and Without Radiotherapy for Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT03217071. IPD Sharing: NO. Countries: 1. Publications: 0.
BLP25 Liposome Vaccine and Bevacizumab After Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer That Cannot Be Removed by
ClinicalTrials.gov study NCT00828009. IPD Sharing: YES. Countries: 1. Publications: 0.
Development of a Model to Predict Progression-Free Survival After Erlotinib in Patients With Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT00897533. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Study of GSK3901961 In Previously Treated Advanced (Metastatic OR Unresectable) Synovial Sarcoma/ Myxoid/Round Cell Liposarcoma, and Previously Treated Metastatic Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT06048705. IPD Sharing: YES. Countries: 6. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.